- Home
- TWLO vs ITCI Comparison
TWLO vs ITCI Comparison
Compare TWLO & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWLO
- ITCI
- Stock Information
- Founded
- TWLO 2008
- ITCI 2002
- Country
- TWLO United States
- ITCI United States
- Employees
- TWLO N/A
- ITCI N/A
- Industry
- TWLO Computer Software: Prepackaged Software
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- TWLO Technology
- ITCI Health Care
- Exchange
- TWLO Nasdaq
- ITCI Nasdaq
- Market Cap
- TWLO 11.4B
- ITCI 13.5B
- IPO Year
- TWLO 2016
- ITCI N/A
- Fundamental
- Price
- TWLO $111.94
- ITCI $126.20
- Analyst Decision
- TWLO Buy
- ITCI Buy
- Analyst Count
- TWLO 23
- ITCI 13
- Target Price
- TWLO $93.74
- ITCI $100.31
- AVG Volume (30 Days)
- TWLO 2.3M
- ITCI 4.3M
- Earning Date
- TWLO 02-13-2025
- ITCI 02-20-2025
- Dividend Yield
- TWLO N/A
- ITCI N/A
- EPS Growth
- TWLO N/A
- ITCI N/A
- EPS
- TWLO N/A
- ITCI N/A
- Revenue
- TWLO $4,339,151,000.00
- ITCI $613,728,000.00
- Revenue This Year
- TWLO $8.62
- ITCI $48.41
- Revenue Next Year
- TWLO $7.82
- ITCI $38.26
- P/E Ratio
- TWLO N/A
- ITCI N/A
- Revenue Growth
- TWLO 5.77
- ITCI 46.08
- 52 Week Low
- TWLO $52.51
- ITCI $62.78
- 52 Week High
- TWLO $117.92
- ITCI $128.00
- Technical
- Relative Strength Index (RSI)
- TWLO 56.46
- ITCI 85.88
- Support Level
- TWLO $105.53
- ITCI $126.00
- Resistance Level
- TWLO $117.92
- ITCI $128.00
- Average True Range (ATR)
- TWLO 3.42
- ITCI 2.35
- MACD
- TWLO -0.26
- ITCI 4.86
- Stochastic Oscillator
- TWLO 51.69
- ITCI 96.18
About TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.